Investigator Initiated Studies

Oxford Immunotec is dedicated to supporting meaningful, independent clinical research conducted by qualified investigators that is consistent with our areas of interest and commitment to improving the care of patients with immune-regulated conditions. Oxford Immunotec may provide funding and other forms of support, such as product and testing services. All physicians, healthcare providers, researchers and institutions worldwide who are interested in conducting their own research are eligible to submit a study proposal.

All proposals are reviewed on their merit by a select review committee. Criteria for approval include scientific merit and alignment with Company areas of interest. Investigator and/or institution responsibilities include study design, execution and compliance with all institutional and regulatory requirements. Support is subject to resource availability and conditioned upon an approved study concept proposal, full study protocol and full execution of a research support agreement by both parties.

Areas of Interest

Including, but not exclusive of:

  • Prospective or retrospective studies to optimise further use of the T-SPOT.TB test as a means of diagnosis; for example (but not limited to), as a means of detecting disease progression
  • Prospective studies to investigate the occurrence of TB infection in other biological samples
  • Scoping data generation in exploratory areas with the T-SPOT.CMV test; for example (but not limited to), use in different transplant types
  • Further exploration in the research use of the T-SPOT® Discovery™ SARS-CoV-2 kit

For more information please click here to download the Investigator Initiated Study Proposal form. Please submit both the cover letter and study protocol to Oxford Immunotec Medical Affairs at researchstudies@oxfordimmunotec.com.